Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer

Hepato-Gastroenterology

Volumn 54, Issue 80, 2007, Pages 2378-2382

  Ishikawa, Toru ^a   Kamimura, Hiroteru ^a   Tsuchiya, Atsunori ^a   Togashi, Tadayuki ^a   Watanabe, Kouji ^a   Seki, Kei Ichi ^a   Ohta, Hironobu ^a   Yoshida, Toshiaki ^a   Takeda, Keiko ^a   Kamimura, Tomoteru ^a  

^a Saiseikai Niigata Second Hospital   (Japan)

Author keywords

Intra arterial regional chemotherapy; Pancreas cancer

Indexed keywords

ANGIOTENSIN II; CISPLATIN; FAMOTIDINE; FLUOROURACIL; GEMCITABINE; GRANISETRON; HEPARIN; UFT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEVER; HAIR LOSS; HUMAN; LIVER DYSFUNCTION; NAUSEA; PANCREAS CANCER; PRIORITY JOURNAL; STOMATITIS; TUMOR VOLUME; XEROSTOMIA;

ANGIOTENSIN II; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 34548489033     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Okusaka T, Matsumura Y, Aoki K: New approaches for pancreatic cancer in Japan. Cancer Chemother Pharmacol 2004; 54:S78-82.
2. Gold EB, Cameron JL: Chronic pancreatitis and pancreatic cancer. N Engl J Med 1993; 328:1485-1486.
3. Sarr MG, Cameron JL: Surgical management of unresectable carcinoma of the pancreas. Surgery 1982; 91:123-133.
4. Wilkowski K, Thoma M, Schauer R, Wagner A, Heinemann V: Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer. World J Surg 2004; 28:1011-1018.
5. Meyer F, Ridwelski K, Gebauer T, Grote R, Martens-Lobenhoffer J, Lippert H: Pharmacokinetics of the anti-neoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma. Chemotherapy 2005; 51:1-8.
6. Bosch X: Fluorouracil and mitomycin for pancreatic cancer. Lancet Oncol 2005; 6:644.
7. Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD: A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996; 7:347-353.
8. Whitehouse PA, Cooper AJ, Johnson CD: Synergistic activity of gamma-linolenic acid and cytotoxic drugs against pancreatic adenocarcinoma cell lines. Pancreatology 2003; 3:367-373.
9. Noguchi S, Miyauchi K, Nishizawa Y, Sasaki Y, Imaoka S, Iwanaga T, Koyama H, Terasawa T: Augmentation of anticancer effect with angiotensin II in intra-arterial infusion chemotherapy for breast carcinoma. Cancer 1988; 62:467-473.
10. Sasaki Y, Imaoka S, Hasegawa Y, Nakano S, Ishikawa O, Ohigashi H, Taniguchi K, Koyama H, Iwanaga T, Terasawa T: Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 1985; 55:311-316.
11. Novarino A, Chiappino I, Bertelli GF, Heouaine A, Ritortob G, Addeo A, Bellone G, Merlano M, Bertetto O: Phase II study of cisplatin, gemcitabine, and 5-fluorouracil in advanced pancreatic cancer. Ann Oncol 2004; 15: 474-477.
12. Miller AB, Hoogstraten B, Staquat M, Winkler A: Reporting results of cancer treatment. Cancer 1981; 47:207-214.
13. World Health Organization: WHO handbook for reporting results of cancer treatment. WHO Offset Publication No. 25. Genova: WHO, 1976.
14. Connolly MM, Dawson PJ, Michelassi F, Moossa AR, Lowenstein F: Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987; 206:366-373.
15. Niederhuber JE, Brennan MF, Menck HR: The National Cancer Data Base report on pancreatic cancer. Cancer1995; 76:1671-1677.
16. Fung MC, Sakata T: What's new in pancreatic cancer treatment? J Hepatobiliary Pancreat Surg 2002; 9:61-75.
17. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15:2403-2413.
18. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot D: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10:1112-1118.
19. Muchmore JH, Preslan JE, George WJ: Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 1996; 78:S664-673.
20. Theodors A, Bukowski RM, Hewlett JS, Livingston RB, Weick JK: Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. Am J Clin Oncol 1982; 5:555-558.
21. Ishikawa T, Kamimura H, Tsuchiya A, Togashi T, Watanabe K, Seki K, Ohta H, Yoshida T, Takeda K, Kamimura T: Angiotensin-II administration is useful for detecting liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography. (In Press)